LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 46 filers reported holding LYRA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,865 | +22.1% | 1,500 | +15.9% | 0.00% | – |
| Q2 2023 | $4,802 | +377.8% | 1,294 | +158.8% | 0.00% | – |
| Q1 2023 | $1,005 | -49.8% | 500 | 0.0% | 0.00% | – |
| Q4 2022 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | +50.0% | 500 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -60.0% | 500 | -59.5% | 0.00% | – |
| Q4 2021 | $5,000 | -58.3% | 1,234 | 0.0% | 0.00% | – |
| Q3 2021 | $12,000 | -66.7% | 1,234 | -72.2% | 0.00% | – |
| Q2 2021 | $36,000 | -92.7% | 4,434 | -89.6% | 0.00% | -100.0% |
| Q1 2021 | $491,000 | +2788.2% | 42,479 | +2752.9% | 0.00% | – |
| Q4 2020 | $17,000 | +54.5% | 1,489 | +51.0% | 0.00% | – |
| Q3 2020 | $11,000 | -38.9% | 986 | -37.8% | 0.00% | – |
| Q2 2020 | $18,000 | – | 1,586 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,100,852 | $12,550,000 | 16.38% |
| Soleus Capital Management, L.P. | 456,138 | $5,199,000 | 0.69% |
| Ikarian Capital, LLC | 815,364 | $9,295,000 | 0.41% |
| Perceptive Advisors | 3,222,561 | $36,737,000 | 0.39% |
| Affinity Asset Advisors, LLC | 50,000 | $570,000 | 0.30% |
| RA Capital Management | 815,849 | $9,301,000 | 0.13% |
| ArrowMark Colorado Holdings LLC | 775,888 | $8,845,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 87,353 | $996,000 | 0.04% |
| Altium Capital Management LP | 5,218 | $59,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 49,000 | $559,000 | 0.01% |